RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH...

86

Transcript of RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH...

Page 1: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 2: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 3: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 4: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 5: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 6: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 7: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 8: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 9: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL

COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER

MEMORIAL HOSPITAL LEVEL II TRAUMA CENTER

WE ARE……………………

Page 10: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Normal TEG

Page 11: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 12: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Army’s Aggressive Surgeon Is Too Aggressive for Some

Erich Schlegel for The New York Times

CRITICAL CARE Col. John Holcomb, a top trauma surgeon in the Army.

SIGN IN TO E-MAIL OR SAVE THIS

PRINT

SINGLE PAGE

REPRINTS

SHARE

By ALEX BERENSON Published: November 6, 2007

Correction Appended

SAN ANTONIO — Since the war in Iraq began, Col. John Holcomb has been working to change the way the military takes care of its wounded.

Page 13: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 14: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 15: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

15

J Trauma, Oct 2008

Page 16: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

16Cosgriff N, et al. Predicting life-threatening coagulopathy in the massively transfused patient: Hypothermia and acidosis revisited. J Trauma. 1997.

“Koolaid”

Acute Traumatic Coagulopathy

Page 17: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

No FFP in trauma resuscitation Old time resuscitation give FFP when

you realize that what is running down your shoes is like “Kool Aid”

1/1/1 Damage Control Resuscitation Thromboelastographic Point of Care

“Goal Directed “Blood Component Therapy

Page 18: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 19: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 20: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 21: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

V.S. BP 115/80, P 124, RR 28 I survey Airway patent, labored breathing,

BS absent on right thready pulse pulse: R hemothorax: respiratory arrest

Intubated, chest tube immediate drain 2000 cc blood right chest

FAST demonstrates pericardial effusion and evidence of right ventricular collapse.

Cardiac surgeon: Pericardial window done in ED Atrial appendage clamped

BCT in ED and in OR based on TEG guided Goal Directed therapy

Page 22: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

CV surgeon and trauma surgeon quickly extend pericardial window

Anesthesiologist and the perfusionist give blood components based on the TEGs. Total 60 PRBC units BCT Ratios: 1PRBC/.5FFP…..1PRBC/1Platelets

Patient needs volume and fibrinogen so given more FFP instead of cryoprecipitate.

Recovers

Page 23: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

FAST Pericardial Window OR BCT lead by anesthesiologist and

perfusionist Fibrinogen given by FFP instead of

cryoprecipitate Decision to close the abdomen Need to take the patient back to surgery Serial TEGs with platelet mapping Platelet count of 42,000 yet good platelet

function TEG/PM guided goal directed BCT

Page 24: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

, U Thoracic and Cardiovascular Surgery. 2009 Volume 13 Number 1

Page 25: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Blue Phantom Ultrasound Training Module

Page 26: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 27: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 28: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 29: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 30: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 31: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 32: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

1) 4 units O- PRBC 2) 2 units FFB 3) 1 SD Apheresis Platelet started in

ER on way to OR 4) Surgical repair of injured colon,

bladder, mesentary with colostomy, intraoperative interventional radiology coiling of bleeding pelvic vessels and external fixation of pelvic fracture.

Page 33: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

1) Initial Fibrinolysis treated with BCT which included cryoprecipitate as well as PRBC, FFP, Platelets with similar ratios as previous cases, i.e.

1 PRBC/.5FFP 1 PRBC/1 Platelet Amicar also given dose 5grams Patient survives

Page 34: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 35: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Damage Control Laparotomy , Colostomy, OR/IR coiling of internal iliac artey branch

Page 36: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Scrotum

External Fixation after Laparotomy and Colostomy

Page 37: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

TOP

Bottom

Scrotum

Page 38: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Good Clot

Page 39: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Hoffman M, Monroe DM, Roberts HR. Human monocytes support factor X activation by factor VIIa independent of tissue factor: implications for the therapeutic mechanism of high dose factor VIIa in hemophilia. 1994 BLOOD83:38-42

Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissuefactor-initiated system. Br J Haematol 1994;88:364–71.

Page 40: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

“Using this model we have evolved a conceptual model of coagulation that better explains the physiology of some clotting and bleeding disorders than does the previous coagulation cascade model.”

From Dr. Hoffman’s Website for Graduate Studies at Duke University

Page 41: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Hoffman M, Monroe DM, Oliver JA, et al. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995;86:1794–801.

Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996;7:459–64.

Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost2001;85:958–65.

Page 42: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

We propose that coagulation occurs not as a "cascade", but in three overlapping stages: 1) initiation, which occurs on a tissue factor bearing cell; 2) amplification, in which platelets and cofactors are activated to set the stage for large scale thrombin generation; and 3) propagation, in which large amounts of thrombin are generated on the platelet surface. This cell based model explains some aspects of hemostasis that a protein-centric model does not.

Page 43: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Furthermore, whereas civilian blunt trauma victims may have a "golden hour," casualties with penetrating battlefield trauma often have only a "platinum 5 minutes." Because of the challenges of treating hemorrhage during combat, it is important for military medical personnel to understand their options for treating hemorrhage quickly and efficiently.

Page 44: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM.

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.

JAMA. 2004 Oct 6;292(13):1555-62.

Page 45: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 46: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 47: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 48: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Currently, 10–15% of patients presenting with ACS have to undergo aorto-coronary artery bypass grafting (CABG) and 5% to 25% of patients have to undergo non-cardiac surgery during the first five years after PCI(7, 8). While preoperative discontinuation of antiplatelet therapy is associated with ∼20% incidence of ischaemic events, continuation puts patients at ∼35% incidence of bleeding (9–11). Likewise, bleeding and transfusion of red blood cells have been associate with increased risk of infection, myocardial infarction and mortality

(13–15). #13 is Dr. Rao’s European Heart Journal

Page 49: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 50: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Based on the results of the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE) and the Trial to assess Improvement in Therapeutic Outcomes by optimizing platelet Inhibition with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITONTIMI 38) current guidelines for cardiac surgery recommend withholding clopidogrel for at least five days and prasugrel at least seven days before scheduled CABG in order to limit blood loss and transfusion (class I recommendation, level of evidence C) (17–19).

Page 51: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

“In TRITONTIMI 38, prasugrel was associated with a significant four-fold increased relative risk (absolute difference: 10.2%) of CABG related bleeding as compared to clopidogrel (19). Furthermore, the observation that a short time interval between clopidogrel withdrawal and surgery precipitates the risk of bleeding, suggests the association between insufficient platelet function recovery and bleeding.”

Page 52: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 53: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 54: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 55: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 56: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

The clinical relevance of platelet function has so far been investigated in cardiology and cardiovascular surgery (7); however, reports on platelet function following trauma are limited (8). Due to logistical problems, routinemeasurement of platelet function can be problematic in the challenging scenario of acute trauma care. Born aggregometry, the current gold standard for the assessment of platelet function, is a labour-intensive technique which is not available in most trauma centres. In contrast, multiple electrode impedance aggregometry (MEA; MultiplateR, Verum Diagnostica GmbH, Munich, Germany)is a newly developed, semi-automated platelet functionanalyser that measures platelet function in whole blood and is readily applicable as a point-of-care monitoring device (9).

Page 57: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 58: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 59: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 60: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248:447-458.

Page 61: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

The Impact of Platelet Transfusion in Massively Transfused Trauma Patients

Kenji Inaba, MD, FACS, Thomas Lustenberger, MD, Peter Rhee, MD, FACS, John B Holcomb, MD, FACS,Lorne H Blackbourne, MD, FACS, Ira Shulman, MD, Janice Nelson, MD, Peep Talving, MD, FACS, Demetrios Demetriades, MD, FACS (J Am Coll Surg 2010;211: 573–579. 2010)

Page 62: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 63: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

78

Page 64: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

79

Total 8 U PRBC, 2 U FFP, 2 SD plts TEG-PM driven not by blind 1:1:1

Page 65: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

80

Page 66: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

History of aspirin use was not given and patient is tachycardic

CT scan 16 cm pelvic hematoma with only a small superior pubic ramus fracture

Internal iliac branch “vessel” tear Coiled Resuscitated with BCT no crystalloid Remembered ASA use. Note quick response to ADP Note still delayed response to AA

Page 67: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 68: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 69: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

37yo female Grade IV Liver Injury Abnormal PM with normal TEG hence

greater ratio of platelets Quick Response to Platelets and

greater ratio of platelets to PRBC for this very significant liver laceration

Page 70: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 71: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 72: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 73: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 74: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 75: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 76: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 77: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 78: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 79: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 80: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.
Page 81: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

Pre TEGPre TEG ( n = 68 )( n = 68 ) Post TEGPost TEG

-13-13 ED : BDED : BD -15-15

1.61.6 ED : INRED : INR 1.81.8

18.018.0 RBC / 6 hrRBC / 6 hr 17.217.2

6.86.8 FFP / 6 hrFFP / 6 hr 6.56.5

65%65% MortalityMortality 29%29%

21%21% CoagulopathyCoagulopathy 3%3%

AAST 2009AAST 2009

Page 82: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

For every one unit drop in G value (clot strength) by one hour, risk of PF increases by 30% and death by >10%

Page 83: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

% Change in Prothrombin Time

% Change in Clot Firmness

Brohi et alJ Trauma 2011

Coagulation Status … after every 4 U RBC( n = 50 Mortality = 36 % )

Page 84: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

MTP Protocol useful MTP underestimates need for BCT Crystalloid infusion for patients in shock is

harmful Historical response to avoidance of

Crystalloid resuscitation harm has bee DCR 1/1/1

How much FFP to give? Resort to the TEG POC “Goal Directed” BCT Fable of the Three Bears

Page 85: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

JUST RIGHT

Page 86: RECENTLY EXPANDED 4 YEAR MEDICAL SCHOOL  COLLABORATION WITH NOTRE DAME’S KECK TRANSGENE REASEACH CENTER  MEMORIAL HOSPITAL LEVEL II.

The code is more what you'd call “guidelines” than actual rules

“Welcome aboard the Black Pearl, Dr. White”

101